|
⚲
|
| Keyboard |
| Borgeson Blake
✚
|
|
|---|---|
| CIK # | 0001856094 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001856094] | |
| 4 | [0001856094] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Borgeson Blake | |
| Recursion Pharmaceuticals Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-03-03 | Sell | 170,000 | $3.46 | 588,200 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-02-03 | Sell | 220,000 | $4.20 | 924,000 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2026-01-06 | Sell | 220,000 | $4.36 | 959,200 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-12-02 | Sell | 220,000 | $4.37 | 961,400 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-06-18 | Grant | 22,016 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Stock Option (Right to Buy) · derivative
|
2025-06-18 | Grant | 44,031 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2025-01-02 | Grant | 1,734 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-11-12 | Sell | 11,447 | $7.64 | 87,455 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-10-29 | Sell | 11,447 | $6.72 | 76,924 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-10-15 | Sell | 11,447 | $6.67 | 76,351 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-10-01 | Grant | 2,026 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-10-01 | Sell | 11,447 | $6.22 | 71,200 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-09-17 | Sell | 11,447 | $6.84 | 78,297 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-09-03 | Sell | 11,447 | $6.27 | 71,773 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-08-20 | Sell | 11,447 | $7.12 | 81,503 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-08-06 | Sell | 11,447 | $6.82 | 78,069 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-07-23 | Sell | 11,447 | $8.48 | 97,071 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-07-09 | Sell | 11,447 | $7.32 | 83,792 |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-07-01 | Grant | 1,441 | $0.00 | |
|
Recursion Pharmaceuticals Inc RXRX
Class A Common Stock
|
2024-06-25 | Sell | 11,447 | $9.51 | 108,861 |
| showing 20 of 94 most recent transactions | |||||